The pharmaco‐economics of peri‐operative statin therapy
Biccard BM., Sear JW., Foëx P.
SummaryWe analysed the pharmaco‐economics of the prospective peri‐operative studies of statin administration for major elective vascular surgery, using the NHS reference costs for 2004. This analysis suggests that peri‐operative statin therapy for patients undergoing vascular surgery may present the most cost‐effective use of statin therapy yet described, with a number‐needed‐to‐treat of 15 and almost 60% of the total cost of atorvastatin therapy recovered through a reduction in peri‐operative adverse events.